4
Changes in Ownership
Royalty Pharma plc Filed Acc 0001802768-25-000063
CEO, Chairman of the Board acquired 530,348 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Legorreta Pablo G. CEO, Chairman of the Board | 2025-05-16 | Other acquisition | +530,348 | 882,495 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Legorreta Pablo G. CEO, Chairman of the Board | 2025-05-16 | Grant or award · Class E Ordinary Shares | +13,356,742 | 13,356,742 | I: show line 2 in the form | |||||
| Legorreta Pablo G. CEO, Chairman of the Board | 2025-05-16 | Other acquisition · Option (Right to Buy) | +857,138 | 857,138 | I: show line 3 in the form |
Loading xslF345X05/wk-form4_1747774159.xml…